Tejinder Kaur Marwaha has a total of 5 co-authors. Here are the top co-authors by number of shared publications:

  • Ashwini Madgulkar

    Department of Pharmaceutics, AISSMS College of Pharmacy, RB Motilal Kennedy Rd, Near RTO, Pune, India

    2 shared publications
  • Kalyani Asgaonkar

    Department of Chemistry, AISSMS College of Pharmacy, Pune, India

    2 shared publications
  • Mangesh Bhalekar

    Department of Pharmaceutics, AISSMS College of Pharmacy, RB Motilal Kennedy Rd, Near RTO, Pune, India

    2 shared publications
  • Pallavi Shewale

    Department of Biotechnology, Savitribaiphule Pune University, Pune, India

    1 shared publication
  • Rajesh Gachche

    Department of Biotechnology, Savitribaiphule Pune University, Pune, India

    1 shared publication

Latest Publications

  • Tailoring the properties of chitosan by grafting with 2-mercaptobenzoic acid to improve mucoadhesion: in silico studies, synthesis and characterization

    by Tejinder K. Marwaha, Ashwini Madgulkar, Mangesh Bhalekar, Kalyani Asgaonkar, Rajesh Gachche, Pallavi Shewale

    Mucoadhesive polymers improve oral bioavailability of drugs by prolonging the duration of adhesion of drugs with mucosa. Various methods could be employed to address the problems of mucoadhesive polymers like weak adhesion forces. Chemical modification of polymers, such as the addition of a thiol group or thiolation, is another way for improving the polymers’ mucoadhesive properties that is studied in present research work. A novel thiomer of chitosan was prepared by attaching 2-mercaptobenzoic acid, a hydrophobic ligand onto it. The docking of thiomer and chitosan with mucin structure showed higher binding energy for former. The prepared thiomer was subjected to X-ray diffraction and DSC which established reduction in crystallinity and formation of a new compound through changes in glass transition, melting point and change in diffraction pattern. The NMR studies established conjugation of 2-mercapto benzoic acid to chitosan. The increased mucoadhesion in thiomer behaviour (2–3 fold) was confirmed through mucus glycoprotein assay as well as through texture analysis. The permeation enhancing the property of thiomer was established by demonstrating the permeation of phenol red across thiomer treated intestinal membrane. An in vitro cell toxicity assay was done to establish toxicity of chitosan and thiolated chitosan. Finally, the reduced water uptake of thiomer over chitosan proved that the increase in mucoadhesion is not contributed by swelling. Thus, a thiomer with improved mucoadhesion and enhanced permeation properties was prepared and characterized. Hence, all these properties render the newly synthesized polymer a better alternative to chitosan as an excipient for mucoadhesive drug delivery systems.


  • Molecular docking, synthesis, and characterization of chitosan‐graft‐2‐mercaptobenzoic acid derivative as potential drug carrier

    by Tejinder Kaur Marwaha, Ashwini Madgulkar, Mangesh Bhalekar, Kalyani Asgaonkar

    Chitosan is a hydrophilic polymer with prominent mucoadhesive properties. However, it forms weak hydrogen bonds with mucin thus limiting its mucoadhesion and exhibit reduced bioavailability due to its short retention time in the body. The aim of the present study was to synthesize and characterize novel thiolated chitosan with improved functional property. A unique approach of using molecular docking to select ligand to chemically modify chitosan has been employed in the present research. A set of ligands were screened virtually using docking analysis and 2‐mercapto benzoic acid showed the lowest glide score of −4.31 Kcal/Mol thus displayed better binding interaction with chitosan. Based on the docking results, the best‐fit ligand was selected for wet lab synthesis. 2‐Mercapto benzoic acid was covalently attached to chitosan via formation of an amide bond and the reaction was mediated by carbodiimide and N‐hydroxysuccinimide. The synthesized polymer was in turn evaluated for zeta potential, Fourier transformed infrared, differential scanning calorimetry, molecular weight that confirmed conjugation of chitosan with the thiol ligand. The prepared thiomer was further subjected to mucoadhesion studies and displayed better mucoadhesion properties as compared to unmodified chitosan. Thus, the potential of the novel thiomer can be further explored as an excipient for drug delivery system with an emphasis on mucoadhesion.


  • FORMULATION DESIGN AND EVALUATION OF HERBAL ANTI PSORIATIC EMULGEL

    by Tejinder Kaur Marwaha

    Psoriasis is an inflammatory condition associated with painful, itchy, scaly skin and disfiguring skin lesions. The lack of possible cure and associated disadvantages in allopathic medicines has led to extensive research in natural products with anti psoriatic activity. Commiphora mukul (Gum guggul) and Psoralea corilyfolia (Babchi oil) were found to be efficacious and cheap anti-inflammatory drugs with least side effects as compared to the synthetic drugs used in the treatment of Psoriasis. Therefore these two drugs were selected for the present study. Considering the above justification an attempt was made to design and develop herbal anti psoriatic topical drug delivery system wherein biphasic drug delivery system of combined herbal drugs in the form of emulgel was formulated and their effect was compared to marketed preparation widely used for treatment of Psoriasis. In the study, topical emulgels of powdered extract of Commiphora mukul and Babchi Oil were formulated. The factorial and optimized batches were evaluated for %EE and %DR followed by in vivo studies. From the in vitro studies, formulation M3 showed maximum release of 79.72%, 94.34% in 6hrs respectively. The formulation M3 was comparable with marketed tacrolimus ointment. The results indicated that the optimized batch containing both the drugs Commiphora mukul (Gum guggul) and Psoralea corilyfolia (Babchi oil) exhibited good results. Thus, the results indicate that an effective herbal formulation containing Commiphora mukul and Babchi oil can be prepared overcoming the side effects posed by synthetic drugs